statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on June 28, 2024 that were previously approved by the Compensation...

Here's How Much You Would Have Made Owning Sarepta Therapeutics Stock In The Last 10 Years

S&P 500 Gains and Losses Today: Index Edges Lower as AI-Fueled Rally Loses Steam

Bloomberg / Contributor / Getty Images

 Key TakeawaysThe S&P 500 fell 0.2% on Friday, June 21, 2024, as the AI-fueled tech rally cooled and data showed a decline in the Conference Board's Leading...

Sarepta's Expanded Approval Unlikely To Influence Novo Holdings' Acquisition of Catalent, But Provides Investor Protection Amid Uncertainty

Catalent shares rise after Sarepta Therapeutics' Elevidys expanded approval. Despite uncertainties, Catalent's risk/reward profile improves.

 Latest Ratings for CTLT
 DateFirmActionFromTo Feb...

Top Stock Movers Now: FactSet, Sarepta Therapeutics, Spirit AeroSystems, and More

Bloomberg / Contributor / Getty Images

 Key TakeawaysThe Dow, S&P 500, and Nasdaq were little changed at midday Friday, June 21, 2024 as reports showed existing home sales and the Conference...

Sarepta Therapeutics Soars on Expanded Approval for Its Muscular Dystrophy Drug

Pavlo Gonchar / SOPA Images / LightRocket via Getty Images

 Key TakeawaysSarepta Therapeutics shares jumped in premarket trading Friday, a day after the biotech firm received Food and Drug...

Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket

Futures Fall, Tech Rally Fades Ahead Of Record $5 Trillion OpEx

Futures Fall, Tech Rally Fades Ahead Of Record $5 Trillion OpEx

 US futures were slightly lower, with tech companies indicating declines as the AI-fueled rally showed signs of fading...

FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy

The FDA has approved Sarepta Therapeutics' Elevidys for treating Duchenne muscular dystrophy in patients aged 4 and older with specific DMD gene mutations.
read more...

5 Things to Know Before the Stock Market Opens

News of the day for June 21, 2024

 David Paul Morris / Bloomberg via Getty Images

Nvidia (NVDA) shares are falling in premarket trading on triple witching day, when stock options...

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Volume	964,539.00
52-Wk High	$173.25
52-Wk Low	$55.25

SRPT Sarepta Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals